PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation
Conditions: Atrial Fibrillation; Intracerebral Hemorrhage Interventions: Drug: Apixaban Oral Tablet; Drug: Dabigatran; Drug: Edoxaban Tablets; Drug: Rivaroxaban Sponsors: Imperial College London; Wuerzburg University Hospital; Julius-Maximilians University; Medical University of Graz; University of Birmingham; King's College London; Hospital Universitari Vall d'Hebron Research Institute; University of Bordeaux; Azienda Osped aliera di Perugia; Aalborg University; STROKE ALLIANCE FOR EUROPE; University Hospital Heidelberg; Cambridge University Hospitals NHS Foundation Trust; Imperial College Healthcare NHS Trust; Mid Yorkshire Hospitals NHS Trust; Hull and East Yorkshire Hospitals NHS Trust; Basildon and Thurrock University Hospitals NHS Foundation Trust; University Hospital Plymouth NHS Trust; King's College Hospital NHS Trust; East Kent Hospitals University NHS Foundation Trust; Northumbria Healthcare NHS Foundation Trust; West Hertfordshir e Hospitals NHS Trust; St Helens & Knowsley Teaching Hospitals NHS Trust; Taunton and Somerset NHS Foundation Trust Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Atrial Fibrillation | Cambridge University | Foundation Trusts | Hemorrhagic Stroke | Hospitals | Pradaxa | Research | Stroke